Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantationacute myeloid leukemia, myelodysplastic syndromeActive, not recruitingPhase 32026-10-05NCT07702578

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
TScan Therapeutics, Inc.5

26 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Banner Health - MD Anderson Cancer CenterGilbertUnited States2
Baylor University Medical CenterDallasUnited States87
City of HopeDuarteUnited States238
Columbia University - Irving Medical CenterNew YorkUnited States2
Dana-Farber Cancer Institute - Hematology/OncologyBostonUnited States2
Froedtert & Medical College of WisconsinMilwaukeeUnited States13
Hackensack University Medical CenterHackensackUnited States308
Honor Health Cancer Transplant InstituteScottsdaleUnited States1
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
Johns Hopkins UniversityBaltimoreUnited States150
Karmanos Cancer InstituteDetroitUnited States153
Massachusetts General HospitalBostonUnited States1015
Memorial Cancer InstituteHollywoodUnited States7
Moffitt Cancer InstituteTampaUnited States2
Mount Sinai HospitalNew YorkUnited States225
Northside HospitalAtlantaUnited States134
Sarah Cannon Research Institute - TriStar Bone Marrow Transplant (BMT)NashvilleUnited States1
SCRI - Colorado Blood Cancer InstituteDenverUnited States2
St. David's South Austin Medical CenterAustinUnited States2
Stanford - School of MedicineStanfordUnited States1
The University of Kansas Cancer CenterKansas CityUnited States5
The University of North Carolina at Chapel HillChapel HillUnited States19
The University of Texas - MD Anderson Cancer CenterHoustonUnited States1
University of ChicagoChicagoUnited States1
University of Colorado - Anschutz Cancer CenterAuroraUnited States2